Occudo Quantitative Strategies LP Pds Biotechnology Corp Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.8 - $6.4 $77,236 - $102,982	-16,091 Reduced 39.77%	24,369 $123,000
Q2 2023 Aug 14, 2023	BUY	$5.03 - $9.9 $203,513 - $400,554	40,460 New	40,460 $203,000
Q3 2022 Nov 14, 2022	BUY	$2.97 - $5.79 $1,220 - $2,379	411 Added 1.86%	22,496 $67,000
Q2 2022 Aug 15, 2022	BUY	$3.05 - $6.68 $67,359 - $147,527	22,085 New	22,085 $81,000

4.22M

170K

6.7K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $38.1M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.